Apoptotic signaling in bufalin- and cinobufagin-treated androgen-dependent and -independent human prostate cancer cells.
about
21-Benzylidene digoxin: a proapoptotic cardenolide of cancer cells that up-regulates Na,K-ATPase and epithelial tight junctions4-O-methylhonokiol, a PPARγ agonist, inhibits prostate tumour growth: p21-mediated suppression of NF-κB activity.Fetuin-A ({alpha}2HS-glycoprotein) is a major serum adhesive protein that mediates growth signaling in breast tumor cellsMiR-181a contributes to bufalin-induced apoptosis in PC-3 prostate cancer cells.Involvement of caspase-3 activity and survivin downregulation in cinobufocini-induced apoptosis in A 549 cells.Bufalin Induces Reactive Oxygen Species Dependent Bax Translocation and Apoptosis in ASTC-a-1 CellsEffects of bufalin on the proliferation of human lung cancer cells and its molecular mechanisms of action.Bufalin-loaded mPEG-PLGA-PLL-cRGD nanoparticles: preparation, cellular uptake, tissue distribution, and anticancer activity.Huachansu suppresses human bladder cancer cell growth through the Fas/Fasl and TNF- alpha/TNFR1 pathway in vitro and in vivoBufalin inhibits TGF-β-induced epithelial-to-mesenchymal transition and migration in human lung cancer A549 cells by downregulating TGF-β receptors.Cinobufagin induces autophagy-mediated cell death in human osteosarcoma U2OS cells through the ROS/JNK/p38 signaling pathway.Triggering apoptotic death of human malignant melanoma a375.s2 cells by bufalin: involvement of caspase cascade-dependent and independent mitochondrial signaling pathwaysCinobufagin Modulates Human Innate Immune Responses and Triggers Antibacterial Activity.Bufalin enhances the antitumor effect of gemcitabine in pancreatic cancerBufalin Reverses HGF-Induced Resistance to EGFR-TKIs in EGFR Mutant Lung Cancer Cells via Blockage of Met/PI3k/Akt Pathway and Induction of Apoptosis.The mechanisms of chansu in inducing efficient apoptosis in colon cancer cells.Cinobufagin inhibits tumor growth by inducing intrinsic apoptosis through AKT signaling pathway in human nonsmall cell lung cancer cells.Inhibitory effect of bufalin on retinoblastoma cells (HXO-RB44) via the independent mitochondrial and death receptor pathway.Development of Certain Protein Kinase Inhibitors with the Components from Traditional Chinese Medicine.Preclinical study of cinobufagin as a promising anti-colorectal cancer agent.Chinese herb cinobufagin-reduced cancer pain is associated with increased peripheral opioids by invaded CD3/4/8 lymphocytes.Bufadienolides and their antitumor activity.Chemical constituents and bioactivities of the skin of Bufo bufo gargarizans Cantor.Toad glandular secretions and skin extractions as anti-inflammatory and anticancer agentsAntitumor effects of traditional Chinese medicine targeting the cellular apoptotic pathway.Bufalin induces apoptosis in vitro and has Antitumor activity against human lung cancer xenografts in vivo.Analysis of proliferation and apoptotic induction by 20 steroid glycosides in 143B osteosarcoma cells in vitro.Cinobufagin exerts anti-proliferative and pro-apoptotic effects through the modulation ROS-mediated MAPKs signaling pathway.Bufalin inhibited the growth of human osteosarcoma MG-63 cells via down-regulation of Bcl-2/Bax and triggering of the mitochondrial pathway.MicroRNA-497 and bufalin act synergistically to inhibit colorectal cancer metastasis.Bufalin exerts antitumor effects by inducing cell cycle arrest and triggering apoptosis in pancreatic cancer cells.Bufalin inhibits the differentiation and proliferation of human osteosarcoma cell line hMG63-derived cancer stem cells.Bufalin alters gene expressions associated DNA damage, cell cycle, and apoptosis in human lung cancer NCI-H460 cells in vitro.Arenobufagin, a natural bufadienolide from toad venom, induces apoptosis and autophagy in human hepatocellular carcinoma cells through inhibition of PI3K/Akt/mTOR pathway.Xenotransplanted human prostate carcinoma (DU145) cells develop into carcinomas and cribriform carcinomas: ultrastructural aspects.Bufalin-inhibited migration and invasion in human osteosarcoma U-2 OS cells is carried out by suppression of the matrix metalloproteinase-2, ERK, and JNK signaling pathways.Urinary metabolites of cinobufagin in rats and their antiproliferative activities.Bufalin and cinobufagin induce apoptosis of human hepatocellular carcinoma cells via Fas- and mitochondria-mediated pathways.Bufadienolide compounds sensitize human breast cancer cells to TRAIL-induced apoptosis via inhibition of STAT3/Mcl-1 pathway.De-acetyl-cinobufalactam monohydrate.
P2860
Q28395505-878FBFB6-D3D4-495D-8E5F-A4E014B01D34Q30414471-605F712B-D1DE-4E08-BA94-4280BBE1C484Q30429199-1F92B0CC-8E70-4962-BFA9-C25ABDEB48F7Q31144343-856B4761-598B-490A-9CFA-146514890813Q33412742-DA7EC82D-C102-4B77-8149-BE5FD102C36DQ33480799-D19BFF8D-DC08-4970-AE0E-A0BC35D55B2CQ34368433-AD93F7E3-3B83-4B7E-A725-88FE0A553CE7Q34377939-809F4334-A3FB-4A68-9255-B431B3C5ED8AQ35162535-6F06BB7C-21E7-4806-9095-5207A68A4210Q35944737-4600D680-7435-4564-B32B-F777E9C275ABQ36017215-C63E65A5-AEA7-4576-AD9C-B7194A956648Q36036784-A7BF288D-91DF-41F7-A690-A350BB49DF9FQ36105090-09C0995B-5761-4150-AC0E-700BDDABDE74Q36424040-C59B42AA-7341-4283-8345-F2DD22577E5CQ36702538-BA7373B2-BE21-4FA4-8EB7-57FD0A3EC3D0Q36931329-99A32EF9-9118-4480-98AC-7EFA7FDEB2FEQ37301710-E6F3577A-2AB0-46EC-B118-67BEBBB9818DQ37448208-EB1EBF44-A85C-4F91-86CB-E1B101721E97Q37570454-7757CC9A-57B4-4DF3-8266-5583E97C4730Q37702397-FD8759F3-7D4C-40B8-BA79-1C9D9553B1CCQ37706923-D21DD5AC-A90B-4F67-B52E-1BDFE02CA759Q37854486-41F4FEC0-A520-403B-B2B2-BB0AA18BC265Q37863659-6179E7D5-6AB4-49EA-A8A9-B95E522D1252Q38204742-90FA1777-631F-4583-A3D7-117F5D64C262Q38521666-F5F168E0-6D51-4069-AB10-FB43E1E4F8E1Q38756541-849E9C10-1F64-461A-8367-F95063DCA52EQ38841438-6D8A33FE-61A3-48B1-B629-DBD0AB038F41Q38873783-94730F7D-6F6E-4796-AAA4-BFADD12FE6B3Q39020808-C66C5A40-6779-45A7-AA16-BDBAD11276D0Q39038746-103F512C-537E-4297-B72D-1D7D3AA16E8AQ39064254-E0A8E70B-8FD6-439C-AAA5-87F3C1D4AAD3Q39100103-D0A1DB19-81F9-4EFF-930E-C74E64F2637EQ39192639-1EB823CF-6B72-4FF0-9289-66633F43350BQ39197590-0EBAD245-6420-4004-8BB7-3C2F915D9BFAQ39268465-34E32605-0301-4F2C-B6F4-5AB92F002324Q39472877-EE1663FD-EBF6-4DE5-90AD-62DD2AC4242DQ39516598-52B04018-1869-40F3-AF38-9E166B233472Q39599072-6BC7BFE5-DDEB-49D2-A03A-316C26F3CFFFQ39603958-D2F3F88F-0328-48B8-B372-0117F164492FQ40499336-452ECE74-1135-415E-B528-D412E25B770D
P2860
Apoptotic signaling in bufalin- and cinobufagin-treated androgen-dependent and -independent human prostate cancer cells.
description
2008 nî lūn-bûn
@nan
2008年の論文
@ja
2008年学术文章
@wuu
2008年学术文章
@zh
2008年学术文章
@zh-cn
2008年学术文章
@zh-hans
2008年学术文章
@zh-my
2008年学术文章
@zh-sg
2008年學術文章
@yue
2008年學術文章
@zh-hant
name
Apoptotic signaling in bufalin ...... t human prostate cancer cells.
@en
Apoptotic signaling in bufalin ...... t human prostate cancer cells.
@nl
type
label
Apoptotic signaling in bufalin ...... t human prostate cancer cells.
@en
Apoptotic signaling in bufalin ...... t human prostate cancer cells.
@nl
prefLabel
Apoptotic signaling in bufalin ...... t human prostate cancer cells.
@en
Apoptotic signaling in bufalin ...... t human prostate cancer cells.
@nl
P2093
P1433
P1476
Apoptotic signaling in bufalin ...... t human prostate cancer cells.
@en
P2093
Ching-Han Yu
Eileen Jea Chien
Hsiao-Fung Pu
Paulus S Wang
Shu-Fen Kan
P2860
P304
P356
10.1111/J.1349-7006.2008.00966.X
P577
2008-11-26T00:00:00Z